Startseite
Reels
Gruppen
Seiten
Mehr sehen
Gruppen Seiten Veranstaltungen Blogs Angebote Jobs
Anmelden Registrieren
Nachtmodus
53BP1 Antibody Market - DNA Damage Response and Cancer Immunotherapy Application
Market Overview The 53BP1 antibody market is experiencing development as this DNA damage response target enables cancer immunotherapy and precision oncology approaches. The global market is projected to exceed USD 3.2 billion through 2030, driven by cancer immunotherapy advancement, biomarker-guided therapy, and clinical trial initiation. 53BP1 antibodies target DNA response through modulation...
0 Kommentare ·0 Geteilt ·3 Ansichten ·0 Bewertungen
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!